Effect of prophylactic injection of magnesium sulfate versus placebo on shivering after cesarean section under spinal anesthesia

Effect of prophylactic injection of magnesium sulfate versus placebo on shivering after cesarean section under spinal anesthesia: a double-blind randomized clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N380

Enrollment

Registered

2021-02-02

Start date

2021-02-13

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shivering. Tremor, unspecified

Interventions

Intervention 1: Intervention group: Intravenous infusion of magnesium sulfate 30 mg/kg in 40 ml normal saline for 15 minutes. Intervention 2: Control group: Intravenous infusion of placebo (distilled

Eligibility

Sex/Gender

Female

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Age of 18 to 45 years old Pregnant women Candidate for cesarean section

Exclusion criteria

Exclusion criteria: Body temperature above 37.5 or below 36 degree centigrade Renal or liver diseases or muscular weakness Uncontrolled thyroiditis disease Parkinson disease Dis-autonomy Raynaud's syndrome Cardiovascular disease Alcohol consumption Taking vasodilator medications

Design outcomes

Primary

Measure	Time frame
Shivering after spinal anesthesia. Timepoint: Every 15 minutes until the end of the patient's presence in the recovery room. Method of measurement: With a clinical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElaheh Sharifi Asa

Hamedan University of Medical Sciences

judiabot1124@gmail.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026